Company attributes
Other attributes
Formerly known as Catalyst eClinical, Kim Walpole, Founder & CEO, and Co-Founder & CTO Tom Walpole founded Trails.ai in 2016. Trials.ai is developing an artificial intelligence system that screens patients as suitable matches for clinical trials.
The Trials.ai Smart Protocol uses data and technology as a screening formula to assist research teams through the process of designing their clinical trials around patients.
Trials.ai was developed as a second opinion option for patients. Trials.ai Patient Burden IndexTM calculates various factors of the patient's symptoms, disease, and outcome before being matched to potential clinical trials.
All clinical investigation starts with the development of a protocol. The protocol is a document that states how a clinical trial will be conducted (the objective(s), design, methods, statistical considerations, and organization,) and ensures the safety of the trial patients and validity of the collected data.
Protocol development assistance covering a wide range of therapeutic areas is available.
